» Articles » PMID: 20117433

The Development of Heart Failure in Patients with Diabetes Mellitus and Pre-clinical Diastolic Dysfunction a Population-based Study

Overview
Date 2010 Feb 2
PMID 20117433
Citations 183
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The purpose of this study was to evaluate the outcomes of pre-clinical diastolic dysfunction in diabetic patients.

Background: Studies have reported a high prevalence of pre-clinical diastolic dysfunction among patients with diabetes mellitus.

Methods: We identified all diabetic patients with a tissue Doppler imaging assessment of diastolic function in Olmsted County, Minnesota, from 2001 to 2007. Diastolic dysfunction was defined as a passive transmitral left ventricular (LV) inflow velocity to tissue Doppler imaging velocity of the medial mitral annulus during passive filling (E/e') ratio >15. The main outcome was the development of heart failure (HF). Secondary outcomes were the development of atrial fibrillation and death.

Results: Overall, 1,760 diabetic patients with a tissue Doppler echocardiographic assessment of diastolic function were identified; 411 (23%) patients had diastolic dysfunction. Using multivariable Cox's proportional hazard modeling, we determined that for every 1-U increase in the passive transmitral LV inflow velocity to tissue Doppler imaging velocity of the medial mitral annulus during passive filling (E/e') ratio, the hazard ratio (HR) of HF increased by 3% (HR: 1.03; 95% confidence interval [CI]: 1.01 to 1.06; p = 0.006) and that diastolic dysfunction was associated with the subsequent development of HF after adjustment for age, sex, body mass index, hypertension, coronary disease, and echocardiographic parameters (HR: 1.61; 95% CI: 1.17 to 2.20; p = 0.003). The cumulative probability of the development of HF at 5 years for diabetic patients with diastolic dysfunction was 36.9% compared with 16.8% for patients without diastolic dysfunction (p < 0.001). Furthermore, diabetic patients with diastolic dysfunction had a significantly higher mortality rate compared with those without diastolic dysfunction.

Conclusions: We demonstrated that an increase in the passive transmitral LV inflow velocity to tissue Doppler imaging velocity of the medial mitral annulus during passive filling (E/e') ratio in diabetic patients is associated with the subsequent development of HF and increased mortality independent of hypertension, coronary disease, or other echocardiographic parameters.

Citing Articles

Echocardiographic and biomarker characteristics in diabetes, coronary artery disease or both: insights from HOMAGE trial.

Monzo L, Kobayashi M, Ferreira J, Lamiral Z, Delles C, Clark A Cardiovasc Diabetol. 2025; 24(1):111.

PMID: 40057728 PMC: 11890510. DOI: 10.1186/s12933-025-02609-8.


Understanding Diabetic Cardiomyopathy: Insulin Resistance and Beyond.

Binu A, Kapoor N Heart Int. 2025; 18(2):7-13.

PMID: 39885933 PMC: 11781369. DOI: 10.17925/HI.2024.18.2.2.


Acid sphingomyelinase downregulation alleviates diabetic myocardial fibrosis in mice.

Chen C, Ji Y, Liu H, Pang L, Chen J, Chen H Mol Cell Biochem. 2025; .

PMID: 39853662 DOI: 10.1007/s11010-025-05206-1.


Effect of trimetazidine on left ventricular functions and cardiac biomarkers in diabetic patients with left ventricular diastolic dysfunction: a randomized controlled trial.

Serag H, Wakeel L, William V, Abdelsalam M, Abdelsalam A, Sayed R Sci Rep. 2025; 15(1):2115.

PMID: 39814796 PMC: 11736023. DOI: 10.1038/s41598-024-83213-w.


Is early use of sodium-glucose cotransporter type 2 inhibitor (SGLT2i) necessary even in diabetic patients without cardiovascular disease: a prospective study regarding the effect of SGLT2i on left ventricular diastolic function.

Jeon K, Jang S, Lee Y, Kim J, Kim D, Chang S J Cardiovasc Imaging. 2025; 33(1):1.

PMID: 39806504 PMC: 11727183. DOI: 10.1186/s44348-024-00043-0.


References
1.
Devereux R, Roman M, Paranicas M, OGrady M, Lee E, Welty T . Impact of diabetes on cardiac structure and function: the strong heart study. Circulation. 2000; 101(19):2271-6. DOI: 10.1161/01.cir.101.19.2271. View

2.
From A, Leibson C, Bursi F, Redfield M, Weston S, Jacobsen S . Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med. 2006; 119(7):591-9. DOI: 10.1016/j.amjmed.2006.05.024. View

3.
Boudina S, Abel E . Diabetic cardiomyopathy revisited. Circulation. 2007; 115(25):3213-23. DOI: 10.1161/CIRCULATIONAHA.106.679597. View

4.
RUBLER S, Dlugash J, YUCEOGLU Y, Kumral T, BRANWOOD A, GRISHMAN A . New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972; 30(6):595-602. DOI: 10.1016/0002-9149(72)90595-4. View

5.
Roger V, Weston S, Redfield M, Hellermann-Homan J, Killian J, Yawn B . Trends in heart failure incidence and survival in a community-based population. JAMA. 2004; 292(3):344-50. DOI: 10.1001/jama.292.3.344. View